Israel Englander Edwards Lifesciences Corp Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $7.9 Million - $8.84 Million	93,700 Added 23.57%	491,300 $45.4 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $18.1 Million - $23.9 Million	-250,100 Reduced 38.61%	397,600 $38 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $6.16 Million - $7.77 Million	-99,900 Reduced 13.36%	647,700 $49.4 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $56.6 Million - $65.6 Million	695,000 Added 1321.29%	747,600 $70.5 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $1.33 Million - $1.51 Million	17,900 Added 51.59%	52,600 $4.35 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $12.8 Million - $16.4 Million	-188,100 Reduced 84.43%	34,700 $2.59 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $17.1 Million - $22.2 Million	207,300 Added 1337.42%	222,800 $18.4 Million

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.